Adult Brain Cancer Support Association in Adelaide, South Australia | Community organisation

Adult Brain Cancer Support Association

Locality: Adelaide, South Australia

Address: The Box Factory Adelaide, SA, Australia

Website: http://adultbraincancersa.org/

Likes: 520

Add/Update information

Reviews

Tags

• Medical and health
• Community group
• Non-profit organisation
• Community organisation

25.01.2022 Commitee members Andy and Rosel feature in one of the Cancer Council's blogs below.

22.01.2022 NDIS Information & Support Session for Brain Tumour Patients & Carers Hosted by Peace of Mind Foundation Thursday 13th August 7:30pm via Zoom

19.01.2022 Unfortunately the Coffee Morning for 28th November has been cancelled due to the latest COVID-19 outbreak in South Australia.

13.01.2022 Please register if you would like to view this important event.

09.01.2022 Very promising news of funding for much needed research. Thanks to Ginta from NRF for the link and The Project's Carrie Bickmore for her passionate advocacy to this cause.

07.01.2022 Today is Childhood Brain Cancer Awareness Day. It is estimated that around 100 children aged 0-14 years are diagnosed with brain cancer each year and that an es...timated 36 children will die from brain cancer in 2020. Childhood brain cancer is the second most common cancer diagnosed in Australian children. The NeuroSurgical Research Foundation is proud to support childhood brain cancer research at the Centre for Cancer Biology, University of South Australia. Research Associate Dr Mel Tea is focused on medulloblastoma, the most common malignant brain tumour in children, frequently occurring in early childhood before the age of five. Treatment for medulloblastoma involves surgical resection, radiation of the brain and spine, and chemotherapy. The five-year survival rates have improved over the last 20 years, however unsurprisingly, exposure of the developing brain to chemotherapy and radiotherapy has detrimental life-long side effects. These include neurological and auditory deficits, secondary cancers and hormonal dysfunction, as well as non-physical deficits such as learning difficulties and psycho-social issues. As a result, Dr Tea says that finding new, less toxic targeted therapies for medulloblastoma is desperately needed. We have identified a new therapeutic target for medulloblastoma, and new experimental drugs for this target that show great promise as a potential new therapy for medulloblastoma. Our aim is to assess this potential new therapeutic approach in advanced preclinical models of medulloblastoma. Successful outcomes will provide impetus for future clinical trials for medulloblastoma treatment, she said.